“…However, many targets, such as thrombin [28,29], platelet-derived growth factor [30,31], prostate specific antigen [32], and vascular endothelial growth factors [33] and MUC1 protein [34], have more than one sites to bind their aptamers or antibodies to form a sandwich structure, which has an obviously better anti-interference ability than the simple biosensing structure [35]. Although lots of E-AB biosensors have been developed to detect these targets based on single-signaling strategy, so far no dual-signaling E-AB biosensors have utilized the aptamer-target-aptamer sandwich structure with both aptamers labeled by redox species for robust detection of the target.…”